Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$77.51M
74 trades · 8 insiders
Net · 90d
$-77.51M
Insiders on file
40
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| WILSON JAMES N | Director | 147 | $0 | $10.55M | 2026-10-15 |
| Vieira Roberto Wandenkolk | President, Oncology | 31 | $0 | $13.95M | 2026-10-02 |
| Lyon Joseph Douglas | See Remarks | 207 | $0 | $33.74M | 2026-10-02 |
| Maduck Sean | See Remarks | 314 | $0 | $70.43M | 2026-10-02 |
| Gunn Justin Frederick | See Remarks | 1 | $0 | $0 | 2026-10-01 |
| Robb Gary Charles | Chief Financial Officer | 212 | $54.6K | $16.06M | 2026-09-24 |
| Mokari Atabak | Chief Financial Officer | 99 | $0 | $27.91M | 2026-09-02 |
| Guyer William | Chief Development Officer | 147 | $0 | $31.07M | 2026-09-01 |
| Park Kimberly | Director | 16 | $0 | $6.54M | 2026-08-26 |
| MAHONEY DAVID L | Director | 93 | $185.0K | $30.12M | 2026-08-18 |
| BELANOFF JOSEPH K | Chief Executive Officer | 85 | $0 | $54.98M | 2026-06-01 |
| Murray Joshua M. | Director | 6 | $0 | $0 | 2026-05-21 |
| Alton Gregg H | Director | 8 | $0 | $0 | 2026-05-21 |
| Swisher Daniel N JR | Director | 121 | $0 | $3.90M | 2026-05-21 |
| BAKER G LEONARD JR | Director, 10% Owner | 132 | $18.62M | $3.61M | 2026-05-21 |
| Hunt Hazel | Chief Scientific Officer | 35 | $0 | $631.9K | 2026-02-27 |
| Cannon Gillian | Director | 10 | $0 | $0 | 2025-09-10 |
| Grauer Andreas | Chief Medical Officer | 3 | $0 | $0 | 2021-02-05 |
| BRADBURY DANIEL | Director | 26 | $498.2K | $729.0K | 2019-02-07 |
| FISHMAN ROBERT S | Chief Medical Officer | 39 | $0 | $1.52M | 2018-11-07 |
| GALA RENEE D | Director | 5 | $155.1K | $0 | 2018-08-20 |
| ENRIGHT PATRICK G | Director, 10% Owner | 69 | $111.4K | $54.69M | 2017-03-16 |
| Tammenoms Bakker Juliet | 10% Owner | 6 | $0 | $1.67M | 2016-12-15 |
| Longitude Venture Partners L.P. | Director, 10% Owner | 16 | $0 | $6.61M | 2016-11-28 |
| Lo Steven | VP Commercial Operations | 22 | $0 | $461.8K | 2015-11-16 |
| LeDoux Anne M | VP & Controller | 6 | $0 | $0 | 2015-09-28 |
| TURNER JOSEPH L | Director | 7 | $20.1K | $0 | 2015-06-18 |
| COOK JOSEPH C JR | Director | 23 | $363.0K | $481.6K | 2015-06-18 |
| Longitude Capital Partners, LLC | 10% Owner | 25 | $111.4K | $7.26M | 2015-03-30 |
| Longitude Capital Associates, L.P. | 10% Owner | 4 | $0 | $1.03M | 2014-05-02 |
| ROE ROBERT L | President and Secretary | 28 | $0 | $420.5K | 2013-01-30 |
| YOUNGER WILLIAM H JR | 10% Owner | 7 | $7.4K | $0 | 2012-08-14 |
| ANDERSON DAVID L | 10% Owner | 6 | $6.9K | $0 | 2012-03-29 |
| Speiser Michael L | 10% Owner | 3 | $92 | $0 | 2012-03-29 |
| SWEET DAVID E | 10% Owner | 6 | $446 | $0 | 2012-03-29 |
| BIRD JEFFREY W | 10% Owner | 3 | $1.6K | $0 | 2012-03-29 |
| SHEEHAN ANDREW T | 10% Owner | 3 | $272 | $0 | 2012-03-29 |
| WHITE JAMES N | 10% Owner | 6 | $38.3K | $0 | 2012-03-29 |
| GAITHER JAMES C | 10% Owner | 3 | $134 | $0 | 2012-03-29 |
| COXE TENCH | 10% Owner | 9 | $46.5K | $0 | 2012-03-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| WILSON JAMES N | Director | S Sale | 2026-10-15 | 2026-10-16 | 300 | $116.30 | $34.9K | 1,054,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-10-15 | 2026-10-16 | 3,046 | $115.39 | $351.5K | 1,054,843 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-10-15 | 2026-10-16 | 6,654 | $114.48 | $761.7K | 1,057,889 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | M Exercise deriv | 2026-10-02 | 2026-10-05 | 8,333 | — | $0 | 133,334 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-10-02 | 2026-10-05 | 5,147 | $116.58 | $600.1K | 3,946 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-10-02 | 2026-10-05 | 2,086 | $115.73 | $241.4K | 9,093 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-10-02 | 2026-10-05 | 1,100 | $114.52 | $126.0K | 11,179 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | M Exercise | 2026-10-02 | 2026-10-05 | 8,333 | $21.63 | $180.2K | 12,279 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-10-02 | 2026-10-05 | 5,833 | — | $0 | 44,167 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-10-02 | 2026-10-05 | 3,357 | — | $0 | 0 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-10-02 | 2026-10-05 | 4,744 | $116.54 | $552.9K | 5,683 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-10-02 | 2026-10-05 | 4,446 | $115.70 | $514.4K | 10,427 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-10-02 | 2026-10-05 | 5,833 | $19.26 | $112.3K | 14,873 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-10-02 | 2026-10-05 | 3,357 | $13.56 | $45.5K | 9,040 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-10-02 | 2026-10-05 | 24,587 | — | $0 | 41,986 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-10-02 | 2026-10-05 | 8,744 | $116.55 | $1.02M | 9,938 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-10-02 | 2026-10-05 | 15,843 | $116.12 | $1.84M | 18,682 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-10-02 | 2026-10-05 | 24,587 | $8.27 | $203.3K | 34,525 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-10-01 | 2026-10-05 | 810 | — | $0 | 3,357 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-10-01 | 2026-10-05 | 810 | $115.40 | $93.5K | 5,683 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-10-01 | 2026-10-05 | 810 | $13.56 | $11.0K | 6,493 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-10-01 | 2026-10-05 | 413 | — | $0 | 66,573 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-10-01 | 2026-10-05 | 413 | $115.54 | $47.7K | 9,938 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-10-01 | 2026-10-05 | 413 | $8.27 | $3.4K | 10,351 | SEC↗ |
| Gunn Justin Frederick | See Remarks | A Award deriv | 2026-10-01 | 2026-10-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-09-24 | 2026-09-28 | 17,100 | — | $0 | 14,056 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-09-24 | 2026-09-28 | 5,000 | — | $0 | 20,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-09-24 | 2026-09-28 | 5,000 | — | $0 | 20,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-09-24 | 2026-09-28 | 5,000 | — | $0 | 20,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-09-24 | 2026-09-28 | 5,000 | — | $0 | 20,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-09-24 | 2026-09-28 | 17,100 | — | $0 | 14,056 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | M Exercise deriv | 2026-09-17 | 2026-09-18 | 17,493 | — | $0 | 182,507 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | M Exercise | 2026-09-17 | 2026-09-18 | 17,493 | $8.27 | $144.7K | 31,156 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | M Exercise deriv | 2026-09-17 | 2026-09-18 | 17,493 | — | $0 | 182,507 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | M Exercise | 2026-09-17 | 2026-09-18 | 17,493 | $8.27 | $144.7K | 31,156 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-16 | 2026-09-18 | 296 | $100.82 | $29.8K | 3,946 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-16 | 2026-09-18 | 296 | $100.82 | $29.8K | 3,946 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-09-15 | 2026-09-16 | 6,800 | $110.27 | $749.8K | 1,067,743 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-09-15 | 2026-09-16 | 400 | $110.84 | $44.3K | 1,067,343 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-09-15 | 2026-09-16 | 2,800 | $111.70 | $312.8K | 1,064,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-09-15 | 2026-09-16 | 2,800 | $111.70 | $312.8K | 1,064,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-09-15 | 2026-09-16 | 400 | $110.84 | $44.3K | 1,067,343 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-09-15 | 2026-09-16 | 6,800 | $110.27 | $749.8K | 1,067,743 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-09-14 | 2026-09-16 | 2,596 | — | $0 | 0 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-09-14 | 2026-09-16 | 7,404 | — | $0 | 4,167 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-09-14 | 2026-09-16 | 2,188 | $114.12 | $249.7K | 5,683 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-09-14 | 2026-09-16 | 7,404 | $13.56 | $100.4K | 15,683 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-09-14 | 2026-09-16 | 7,812 | $113.32 | $885.3K | 7,871 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-09-14 | 2026-09-16 | 2,596 | $11.35 | $29.5K | 8,279 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-09-14 | 2026-09-16 | 7,404 | — | $0 | 4,167 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise deriv | 2026-09-14 | 2026-09-16 | 2,596 | — | $0 | 0 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-09-14 | 2026-09-16 | 2,188 | $114.12 | $249.7K | 5,683 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-09-14 | 2026-09-16 | 7,812 | $113.32 | $885.3K | 7,871 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-09-14 | 2026-09-16 | 7,404 | $13.56 | $100.4K | 15,683 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | M Exercise | 2026-09-14 | 2026-09-16 | 2,596 | $11.35 | $29.5K | 8,279 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | M Exercise deriv | 2026-09-02 | 2026-09-03 | 58,333 | — | $0 | 141,667 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | F Tax w/h | 2026-09-02 | 2026-09-03 | 72 | $113.38 | $8.2K | 5,683 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 974 | $112.40 | $109.5K | 12,694 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | F Tax w/h | 2026-09-02 | 2026-09-03 | 102 | $113.38 | $11.6K | 4,242 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | M Exercise | 2026-09-02 | 2026-09-03 | 58,333 | $21.63 | $1.26M | 62,575 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 23,600 | $109.35 | $2.58M | 38,975 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 23,770 | $110.70 | $2.63M | 15,205 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 1,537 | $111.37 | $171.2K | 13,668 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 1,606 | $113.72 | $182.6K | 11,088 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 5,621 | $114.58 | $644.1K | 5,467 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 1,225 | $115.44 | $141.4K | 4,242 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 91 | $113.38 | $10.3K | 13,663 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 102 | $113.38 | $11.6K | 16,304 | SEC↗ |
| Maduck Sean | See Remarks | F Tax w/h | 2026-09-02 | 2026-09-03 | 117 | $113.38 | $13.3K | 9,938 | SEC↗ |
| Maduck Sean | See Remarks | F Tax w/h | 2026-09-02 | 2026-09-03 | 117 | $113.38 | $13.3K | 9,938 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 102 | $113.38 | $11.6K | 16,304 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 91 | $113.38 | $10.3K | 13,663 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | M Exercise deriv | 2026-09-02 | 2026-09-03 | 58,333 | — | $0 | 141,667 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 1,225 | $115.44 | $141.4K | 4,242 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 5,621 | $114.58 | $644.0K | 5,467 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 1,606 | $113.72 | $182.6K | 11,088 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 974 | $112.40 | $109.5K | 12,694 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 1,537 | $111.37 | $171.2K | 13,668 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 23,770 | $110.70 | $2.63M | 15,205 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2026-09-02 | 2026-09-03 | 23,600 | $109.35 | $2.58M | 38,975 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | M Exercise | 2026-09-02 | 2026-09-03 | 58,333 | $21.63 | $1.26M | 62,575 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | F Tax w/h | 2026-09-02 | 2026-09-03 | 102 | $113.38 | $11.6K | 4,242 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | F Tax w/h | 2026-09-02 | 2026-09-03 | 72 | $113.38 | $8.2K | 5,683 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-09-01 | 2026-09-03 | 25,000 | — | $0 | 66,986 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 130 | $113.38 | $14.7K | 5,625 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 130 | — | $0 | 5,755 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | A Award | 2026-09-01 | 2026-09-03 | 138 | $113.38 | $15.6K | 4,206 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | A Award | 2026-09-01 | 2026-09-03 | 138 | — | $0 | 4,344 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | — | $0 | 13,754 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | $113.38 | $18.6K | 13,590 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | A Award | 2026-09-01 | 2026-09-03 | 138 | $113.38 | $15.6K | 16,268 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | A Award | 2026-09-01 | 2026-09-03 | 138 | — | $0 | 16,406 | SEC↗ |
| Maduck Sean | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 150 | — | $0 | 10,055 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-09-01 | 2026-09-03 | 25,000 | $8.27 | $206.8K | 34,755 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-09-01 | 2026-09-03 | 10,989 | $114.71 | $1.26M | 12,036 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-09-01 | 2026-09-03 | 2,281 | $115.61 | $263.7K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 150 | $113.38 | $17.0K | 9,905 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-09-01 | 2026-09-03 | 11,730 | $113.94 | $1.34M | 23,025 | SEC↗ |
| Guyer William | Chief Development Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | — | $0 | 4,313 | SEC↗ |
| Guyer William | Chief Development Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | $113.38 | $18.6K | 4,149 | SEC↗ |
| Guyer William | Chief Development Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | — | $0 | 4,313 | SEC↗ |
| Guyer William | Chief Development Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | $113.38 | $18.6K | 4,149 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-09-01 | 2026-09-03 | 25,000 | — | $0 | 66,986 | SEC↗ |
| Maduck Sean | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 150 | — | $0 | 10,055 | SEC↗ |
| Maduck Sean | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 150 | $113.38 | $17.0K | 9,905 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-09-01 | 2026-09-03 | 2,281 | $115.61 | $263.7K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-09-01 | 2026-09-03 | 10,989 | $114.71 | $1.26M | 12,036 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-09-01 | 2026-09-03 | 11,730 | $113.94 | $1.34M | 23,025 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-09-01 | 2026-09-03 | 25,000 | $8.27 | $206.8K | 34,755 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | A Award | 2026-09-01 | 2026-09-03 | 138 | — | $0 | 16,406 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | A Award | 2026-09-01 | 2026-09-03 | 138 | $113.38 | $15.6K | 16,268 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | — | $0 | 13,754 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | A Award | 2026-09-01 | 2026-09-03 | 164 | $113.38 | $18.6K | 13,590 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | A Award | 2026-09-01 | 2026-09-03 | 138 | — | $0 | 4,344 | SEC↗ |
| Vieira Roberto Wandenkolk | President, Oncology | A Award | 2026-09-01 | 2026-09-03 | 138 | $113.38 | $15.6K | 4,206 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 130 | — | $0 | 5,755 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | A Award | 2026-09-01 | 2026-09-03 | 130 | $113.38 | $14.7K | 5,625 | SEC↗ |
| Park Kimberly | Director | M Exercise deriv | 2026-08-26 | 2026-08-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Park Kimberly | Director | S Sale | 2026-08-26 | 2026-08-28 | 26,685 | $122.55 | $3.27M | 0 | SEC↗ |
| Park Kimberly | Director | M Exercise | 2026-08-26 | 2026-08-28 | 30,000 | $13.49 | $404.7K | 30,000 | SEC↗ |
| Park Kimberly | Director | F Tax w/h | 2026-08-26 | 2026-08-28 | 3,315 | $122.09 | $404.7K | 26,685 | SEC↗ |
| Park Kimberly | Director | M Exercise deriv | 2026-08-26 | 2026-08-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Park Kimberly | Director | S Sale | 2026-08-26 | 2026-08-28 | 26,685 | $122.55 | $3.27M | 0 | SEC↗ |
| Park Kimberly | Director | F Tax w/h | 2026-08-26 | 2026-08-28 | 3,315 | $122.09 | $404.7K | 26,685 | SEC↗ |
| Park Kimberly | Director | M Exercise | 2026-08-26 | 2026-08-28 | 30,000 | $13.49 | $404.7K | 30,000 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-25 | 2026-08-27 | 30,955 | — | $0 | 169,045 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-25 | 2026-08-27 | 25,085 | $125.47 | $3.15M | 15,625 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-25 | 2026-08-27 | 30,955 | $11.35 | $351.3K | 40,710 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-25 | 2026-08-27 | 5,870 | $126.06 | $740.0K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-25 | 2026-08-27 | 30,955 | — | $0 | 169,045 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-25 | 2026-08-27 | 5,870 | $126.06 | $740.0K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-25 | 2026-08-27 | 25,085 | $125.47 | $3.15M | 15,625 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-25 | 2026-08-27 | 30,955 | $11.35 | $351.3K | 40,710 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 4,984 | $117.47 | $585.5K | 1,232,161 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 7,055 | $118.88 | $838.7K | 1,133,939 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 400 | $119.64 | $47.9K | 1,133,539 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 91,167 | $118.24 | $10.78M | 1,140,994 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 400 | $119.64 | $47.9K | 1,133,539 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 7,055 | $118.88 | $838.7K | 1,133,939 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 91,167 | $118.24 | $10.78M | 1,140,994 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-08-18 | 2026-08-20 | 4,984 | $117.47 | $585.5K | 1,232,161 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | S Sale | 2026-08-17 | 2026-08-18 | 10,000 | $116.26 | $1.16M | 39,716 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-17 | 2026-08-18 | 125 | — | $0 | 13,426 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | S Sale | 2026-08-17 | 2026-08-18 | 10,000 | $116.26 | $1.16M | 39,716 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-17 | 2026-08-18 | 125 | — | $0 | 13,426 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-14 | 2026-08-18 | 3,664 | — | $0 | 91,986 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-08-14 | 2026-08-18 | 4,668 | $111.44 | $520.2K | 1,076,822 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-08-14 | 2026-08-18 | 2,279 | $112.64 | $256.7K | 1,074,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-08-14 | 2026-08-18 | 3,053 | $110.49 | $337.3K | 1,081,490 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-14 | 2026-08-18 | 3,664 | $114.49 | $419.5K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-14 | 2026-08-18 | 3,664 | $8.27 | $30.3K | 13,419 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-14 | 2026-08-18 | 3,664 | — | $0 | 91,986 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-14 | 2026-08-18 | 3,664 | $114.49 | $419.5K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-14 | 2026-08-18 | 3,664 | $8.27 | $30.3K | 13,419 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-08-14 | 2026-08-18 | 2,279 | $112.64 | $256.7K | 1,074,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-08-14 | 2026-08-18 | 4,668 | $111.44 | $520.2K | 1,076,822 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-08-14 | 2026-08-18 | 3,053 | $110.49 | $337.3K | 1,081,490 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-12 | 2026-08-14 | 3,000 | — | $0 | 15,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-12 | 2026-08-14 | 11,530 | — | $0 | 13,551 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-12 | 2026-08-14 | 3,000 | — | $0 | 15,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-12 | 2026-08-14 | 3,000 | — | $0 | 15,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-12 | 2026-08-14 | 3,000 | — | $0 | 15,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-08-12 | 2026-08-14 | 11,530 | — | $0 | 13,551 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 16,300 | — | $0 | 110,000 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-10 | 2026-08-12 | 1,031 | — | $0 | 95,650 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-08-10 | 2026-08-12 | 16,300 | $21.65 | $352.9K | 20,285 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-08-10 | 2026-08-12 | 4,770 | $114.04 | $544.0K | 3,985 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-08-10 | 2026-08-12 | 11,530 | $113.18 | $1.30M | 8,755 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-10 | 2026-08-12 | 1,031 | $114.52 | $118.1K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-10 | 2026-08-12 | 1,031 | $8.27 | $8.5K | 10,786 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-10 | 2026-08-12 | 1,031 | — | $0 | 95,650 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-10 | 2026-08-12 | 1,031 | $114.52 | $118.1K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-10 | 2026-08-12 | 1,031 | $8.27 | $8.5K | 10,786 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 16,300 | — | $0 | 110,000 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-08-10 | 2026-08-12 | 4,770 | $114.04 | $544.0K | 3,985 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-08-10 | 2026-08-12 | 11,530 | $113.18 | $1.30M | 8,755 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-08-10 | 2026-08-12 | 16,300 | $21.65 | $352.9K | 20,285 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-08-04 | 2026-08-06 | 3,700 | — | $0 | 126,300 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-08-04 | 2026-08-06 | 3,700 | $21.65 | $80.1K | 7,685 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-08-04 | 2026-08-06 | 3,700 | $113.12 | $418.5K | 3,985 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-08-04 | 2026-08-06 | 3,700 | — | $0 | 126,300 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-08-04 | 2026-08-06 | 3,700 | $113.12 | $418.6K | 3,985 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-08-04 | 2026-08-06 | 3,700 | $21.65 | $80.1K | 7,685 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-03 | 2026-08-05 | 20,305 | — | $0 | 96,681 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-08-03 | 2026-08-05 | 1,540 | $114.16 | $175.8K | 5,495 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-03 | 2026-08-05 | 20,305 | $114.70 | $2.33M | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-03 | 2026-08-05 | 20,305 | $8.27 | $167.9K | 30,060 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-08-03 | 2026-08-05 | 20,305 | — | $0 | 96,681 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-08-03 | 2026-08-05 | 20,305 | $114.70 | $2.33M | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-08-03 | 2026-08-05 | 20,305 | $8.27 | $167.9K | 30,060 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-08-03 | 2026-08-05 | 1,540 | $114.16 | $175.8K | 5,495 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-08-03 | 80,000 | — | $0 | 95,833 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 4,200 | $105.54 | $443.3K | 91,930 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-08-03 | 80,000 | $23.06 | $1.84M | 96,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 14,222 | $115.87 | $1.65M | 45,373 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 15,477 | $114.96 | $1.78M | 59,595 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 4,700 | $113.18 | $531.9K | 75,072 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 600 | $110.95 | $66.6K | 79,772 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 2,202 | $110.03 | $242.3K | 80,372 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 400 | $108.46 | $43.4K | 82,574 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 8,956 | $106.96 | $957.9K | 82,974 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 1,001 | $120.67 | $120.8K | 16,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 8,103 | $119.95 | $972.0K | 17,131 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 4,783 | $118.73 | $567.9K | 25,234 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 8,267 | $117.93 | $974.9K | 30,017 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 7,089 | $116.96 | $829.1K | 38,284 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-08-03 | 80,000 | — | $0 | 95,833 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 1,001 | $120.67 | $120.8K | 16,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 8,103 | $119.95 | $971.9K | 17,131 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 4,783 | $118.73 | $567.9K | 25,234 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 8,267 | $117.93 | $975.0K | 30,017 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 7,089 | $116.96 | $829.1K | 38,284 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 14,222 | $115.87 | $1.65M | 45,373 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 15,477 | $114.96 | $1.78M | 59,595 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 4,700 | $113.18 | $531.9K | 75,072 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 600 | $110.95 | $66.6K | 79,772 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 2,202 | $110.03 | $242.3K | 80,372 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 400 | $108.46 | $43.4K | 82,574 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 8,956 | $106.96 | $957.9K | 82,974 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-30 | 2026-08-03 | 4,200 | $105.54 | $443.2K | 91,930 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-08-03 | 80,000 | $23.06 | $1.84M | 96,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise deriv | 2026-07-15 | 2026-07-17 | 15,833 | — | $0 | 4,167 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise deriv | 2026-07-15 | 2026-07-17 | 24,167 | — | $0 | 175,833 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise | 2026-07-15 | 2026-07-17 | 24,167 | $23.06 | $557.3K | 56,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-15 | 2026-07-17 | 7,919 | $86.78 | $687.2K | 48,211 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-15 | 2026-07-17 | 28,460 | $87.89 | $2.50M | 19,751 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-15 | 2026-07-17 | 3,520 | $88.30 | $310.8K | 16,231 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-07-15 | 2026-07-17 | 101 | $89.43 | $9.0K | 16,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise | 2026-07-15 | 2026-07-17 | 15,833 | $19.26 | $304.9K | 31,963 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-07-15 | 2026-07-17 | 2,974 | $88.81 | $264.1K | 1,086,521 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-07-15 | 2026-07-17 | 1,978 | $89.49 | $177.0K | 1,084,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-07-15 | 2026-07-17 | 3,969 | $87.74 | $348.2K | 1,089,495 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-07-15 | 2026-07-17 | 1,079 | $86.78 | $93.6K | 1,093,464 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-07-07 | 2026-07-08 | 20,000 | — | $0 | 130,000 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-07-07 | 2026-07-08 | 952 | $93.54 | $89.1K | 3,985 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-07-07 | 2026-07-08 | 19,048 | $93.11 | $1.77M | 4,937 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-07-07 | 2026-07-08 | 20,000 | $21.65 | $433.0K | 23,985 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-07-01 | 2026-07-06 | 25,000 | — | $0 | 116,986 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-07-01 | 2026-07-06 | 11,175 | $89.31 | $998.0K | 9,755 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-07-01 | 2026-07-06 | 25,000 | $8.27 | $206.8K | 34,755 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-07-01 | 2026-07-06 | 2,801 | $88.51 | $247.9K | 20,930 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-07-01 | 2026-07-06 | 11,024 | $87.33 | $962.7K | 23,731 | SEC↗ |
| MAHONEY DAVID L | Director | S Sale | 2026-06-17 | 2026-06-18 | 20,000 | $84.53 | $1.69M | 26,147 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-06-16 | 2026-06-18 | 5,823 | $83.57 | $486.6K | 1,094,543 | SEC↗ |
| WILSON JAMES N | Director | S Sale | 2026-06-16 | 2026-06-18 | 4,177 | $82.69 | $345.4K | 1,100,366 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise deriv | 2026-06-15 | 2026-06-17 | 40,000 | — | $0 | 20,000 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise | 2026-06-15 | 2026-06-17 | 40,000 | $19.26 | $770.4K | 56,130 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-06-15 | 2026-06-17 | 19,483 | $81.81 | $1.59M | 16,132 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-06-15 | 2026-06-17 | 11,081 | $80.94 | $896.9K | 35,615 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-06-15 | 2026-06-17 | 9,434 | $80.02 | $754.9K | 46,696 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-06-15 | 2026-06-17 | 2 | $82.45 | $165 | 16,130 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-06-02 | 2026-06-04 | 20,000 | — | $0 | 150,000 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | F Tax w/h | 2026-06-02 | 2026-06-03 | 358 | $70.44 | $25.2K | 25,681 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | F Tax w/h | 2026-06-02 | 2026-06-03 | 395 | $70.44 | $27.8K | 16,130 | SEC↗ |
| Maduck Sean | See Remarks | F Tax w/h | 2026-06-02 | 2026-06-03 | 452 | $70.44 | $31.8K | 9,755 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | F Tax w/h | 2026-06-02 | 2026-06-03 | 269 | $70.44 | $18.9K | 7,035 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-06-02 | 2026-06-04 | 20,000 | $21.65 | $433.0K | 23,985 | SEC↗ |
| Guyer William | Chief Development Officer | S Sale | 2026-06-02 | 2026-06-04 | 20,000 | $70.60 | $1.41M | 3,985 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise deriv | 2026-06-01 | 2026-06-03 | 40,000 | — | $0 | 60,000 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-06-01 | 2026-06-03 | 25,000 | — | $0 | 141,986 | SEC↗ |
| BELANOFF JOSEPH K | Chief Executive Officer | S Sale | 2026-06-01 | 2026-06-02 | 12,837 | $69.74 | $895.3K | 2,565,489 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | A Award | 2026-06-01 | 2026-06-03 | 776 | — | $0 | 26,039 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | A Award | 2026-06-01 | 2026-06-03 | 776 | $70.44 | $54.7K | 25,263 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | A Award | 2026-06-01 | 2026-06-03 | 634 | — | $0 | 16,525 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | A Award | 2026-06-01 | 2026-06-03 | 634 | $70.44 | $44.7K | 15,891 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | S Sale | 2026-06-01 | 2026-06-03 | 40,000 | $70.00 | $2.80M | 15,257 | SEC↗ |
| Mokari Atabak | Chief Financial Officer | M Exercise | 2026-06-01 | 2026-06-03 | 40,000 | $19.26 | $770.4K | 55,257 | SEC↗ |
| Maduck Sean | See Remarks | A Award | 2026-06-01 | 2026-06-03 | 615 | — | $0 | 10,207 | SEC↗ |
| Maduck Sean | See Remarks | A Award | 2026-06-01 | 2026-06-03 | 615 | $70.44 | $43.3K | 9,592 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-06-01 | 2026-06-03 | 3,931 | $70.75 | $278.1K | 8,977 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-06-01 | 2026-06-03 | 21,069 | $70.11 | $1.48M | 12,908 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-06-01 | 2026-06-03 | 25,000 | $8.27 | $206.8K | 33,977 | SEC↗ |
| Guyer William | Chief Development Officer | A Award | 2026-06-01 | 2026-06-03 | 877 | $70.44 | $61.8K | 3,108 | SEC↗ |
| Guyer William | Chief Development Officer | A Award | 2026-06-01 | 2026-06-03 | 877 | — | $0 | 3,985 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | A Award | 2026-06-01 | 2026-06-03 | 537 | $70.44 | $37.8K | 6,767 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | A Award | 2026-06-01 | 2026-06-03 | 537 | — | $0 | 7,304 | SEC↗ |
| BELANOFF JOSEPH K | Chief Executive Officer | G Gift | 2026-05-29 | 2026-06-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BELANOFF JOSEPH K | Chief Executive Officer | G Gift | 2026-05-29 | 2026-06-02 | 300,000 | — | $0 | 2,578,326 | SEC↗ |
| BELANOFF JOSEPH K | Chief Executive Officer | G Gift | 2026-05-29 | 2026-06-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-05-27 | 2026-07-08 | 600 | — | $0 | 25,081 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise deriv | 2026-05-27 | 2026-05-29 | 75,000 | — | $0 | 166,986 | SEC↗ |
| WILSON JAMES N | Director | G Gift | 2026-05-27 | 2026-05-29 | 9,011 | — | $0 | 0 | SEC↗ |
| WILSON JAMES N | Director | G Gift | 2026-05-27 | 2026-05-29 | 9,011 | — | $0 | 1,104,543 | SEC↗ |
| WILSON JAMES N | Director | G Gift | 2026-05-27 | 2026-05-29 | 892,056 | — | $0 | 9,011 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-05-27 | 2026-05-29 | 20,425 | $66.16 | $1.35M | 8,977 | SEC↗ |
| Maduck Sean | See Remarks | M Exercise | 2026-05-27 | 2026-05-29 | 75,000 | $8.27 | $620.3K | 83,977 | SEC↗ |
| Maduck Sean | See Remarks | S Sale | 2026-05-27 | 2026-05-29 | 54,575 | $65.37 | $3.57M | 29,402 | SEC↗ |
| Lyon Joseph Douglas | See Remarks | S Sale | 2026-05-27 | 2026-05-29 | 5,000 | $65.00 | $325.0K | 6,230 | SEC↗ |
| Park Kimberly | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MAHONEY DAVID L | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Murray Joshua M. | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Swisher Daniel N JR | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| WILSON JAMES N | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Alton Gregg H | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BAKER G LEONARD JR | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-05-13 | 2026-05-15 | 5,300 | — | $0 | 24,487 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-05-13 | 2026-05-15 | 1,000 | — | $0 | 12,571 | SEC↗ |
| Robb Gary Charles | Chief Business Officer | G Gift | 2026-05-13 | 2026-05-15 | 1,000 | — | $0 | 12,571 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise deriv | 2026-05-05 | 2026-05-07 | 20,000 | — | $0 | 170,000 | SEC↗ |
| Guyer William | Chief Development Officer | M Exercise | 2026-05-05 | 2026-05-07 | 20,000 | $21.65 | $433.0K | 22,231 | SEC↗ |